Skip to content

JACARDI: A eHealth and Health Literacy Educational Training to Support Older Patients With Type II Diabetes

JACARDI: A eHealth and Health Literacy Educational Training to Support Older Patients With Type II Diabetes

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06904690
Acronym
JACARDI
Enrollment
200
Registered
2025-04-01
Start date
2024-11-15
Completion date
2026-03-31
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

Type 2 diabetes, eHealth literacy, elderly subjects, wellbeing, quality of life

Brief summary

The JACARDI trial is a multicenter study involving an educational training, with the general objective to improve the eHealth of older adults in relation to the management of type 2 diabetes.

Detailed description

The JACARDI trial is a multicentric study organized as a blended didactic and interactive educational training, with the general objective to improve the eHealth of older adults in relation to the management of type 2 diabetes, thus contributing to independent living, and reduce risks of negative consequences for the health status and quality of life. The trial will be preceded by a pre-study, needed to personalize and finalize the contents of the training, together with the beneficiaries of the study. In particular, during the pre-study, a population with similar characteristics of the target group will be involved in focus groups to refine the contents and practicalities of the training before the recruitment starts. The primary end-point of the JACARDI trial is the improvement of the eHealth literacy after the conduction of the training, to be measured through the eHEALS scale, after 10 weeks of training. The training consisting of 5 modules and will be conducted over 10 weeks (one session every other week), with each session lasting an average of 90 minutes.

Interventions

The educational training is divided into the following five modules: Module 1: Raising Awareness of eHealth and Health Literacy (Introduction to the aims and context of JACARDI and diabetes); Module 2: Acquiring New Knowledge (Health Literacy and Self-Management of Diabetes); Module 3: Acquiring New Knowledge (Technological and Non-Technological Strategies to Support the Self-Management of Diabetes); Module 4: Practicing New Skills (Usability with Practice Sessions); Module 5: Self-Evaluation and Sustainability of Improvement (Final Questionnaire). The training will be conducted over 10 weeks (one session every other week), with each session lasting an average of 90 minutes.

Sponsors

European Union
CollaboratorOTHER
Istituto Nazionale di Ricovero e Cura per Anziani
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Low eHealth literacy (eHeals scale ≤ 29) * No acute or untreated medical problems * Mini Mental State Examination (MMSE) ≥ 24 * Geriatric Depression Scale (GDS) \< 2

Exclusion criteria

* A myocardial infarction or stroke within 6 months * Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility * Uncontrolled hypertension * Advanced Parkinson's disease or other neuromuscular disorder * Metastatic cancer or immunosuppressive therapy * Significant visual or hearing impairment

Design outcomes

Primary

MeasureTime frameDescription
eHealth literacyBaseline and 10, 14 and 34 weeks laterMeasured using the eHealth Literacy Scale (eHEALS). Scores range from 8 to 40, with higher scores indicating higher eHealth literacy.

Secondary

MeasureTime frameDescription
Health literacyBaseline and 10, 14 and 34 weeks laterMeasured using the 16 items European Health Literacy Survey Questionnaire (HLS-EU-Q16). Each of the 16 items is answered by choosing one response from those available: 'very difficult', 'fairly difficult', 'fairly easy' and 'very easy. The four response categories are binarized (1 = very easy / fairly easy; 0 = very difficult / fairly difficult) and added together to form a total score: adequate (13-16 points), problematic (9-12 points) and inadequate (1-8 points).
Health-related quality of lifeBaseline and 10, 14 and 34 weeks laterMeasured using the 5-level EQ-5D version (EQ-5D-5L) from the EuroQol Group. It includes one item addressing each of five dimensions (mobility, self-care, usual activity, pain/discomfort, and anxiety/depression). Participants rate each of these items from 1 of the 5 levels: no problems, slight problems, moderate problems, severe problems, or unable to/extreme. A composite health state is then defined by combining the levels for each dimension into a 5-digit number.
Psychological well-beingBaseline and 10, 14 and 34 weeks laterMeasured by the Psychological Wellbeing Scale (PWB). A self-administered questionnaire consisting of 18 items that investigates the degree of psychological well-being by exploring six dimensions: self-acceptance, positive relationships with others, autonomy, environmental control, personal growth, and purpose of life. The questionnaire consists of 18 items on a 4-step Likert scale. The higher numbers indicate greater agreement with positive statements or disagreement with negative statements. Scores are calculated for each of the six dimensions by summing or averaging the responses to the items within that dimension.
Diabetes related emotional distressBaseline and 10, 14 and 34 weeks laterMeasured by the Problem Areas in Diabetes Questionnaire (PAID). The PAID is a self-report questionnaire that contains 20 items describing negative emotions related to diabetes (e.g. fear, anger, frustration) commonly experienced by patients with diabetes. Each question has five possible answers with a value from 0 (no problem) to 4 (a serious problem).Scores range from 0 - 100, higer scores indicate worse outcome.

Countries

Italy

Contacts

Primary ContactAnna Rita Bonfigli
a.bonfigli@inrca.it0718003719

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026